Medications
Merck warns doctors to stop prescribing Tredaptive
Drugmaker Merck says it is suspending its sale of the cholesterol drug Tredaptive and is telling doctors to quit prescribing the medicine.
Jan 11, 2013
0
0
Page 12 - News tagged with cholesterol drugs
Medications
FDA approves juxtapid for rare cholesterol disorder
(HealthDay)—The U.S. Food and Drug Administration has approved the orphan drug Juxtapid (lomitapide) for patients with homozygous familial hypercholesterolemia (HoFH), for use in combination with a low-fat diet and other ...
Dec 27, 2012
0
0
Cardiology
Tips for having a heart-healthy holiday
(Medical Xpress)—It's the season of joy, peace and goodwill, but it's also the time of year that brings a spike in heart attacks with most occurring on Christmas Day, Boxing Day and New Year's Day.
Dec 21, 2012
0
0
Medications
Merck says cholesterol drug failed to show benefit
Drugmaker Merck & Co. said it will not seek U.S. approval for its cholesterol drug Tredaptive and is recommending doctors abroad stop prescribing it to new patients, based on failed study results.
Dec 20, 2012
0
0
Medications
Drugmaker Ranbaxy halts generic Lipitor production
Problem-plagued Ranbaxy Pharmaceuticals Inc. has halted production of generic cholesterol drug Lipitor while it investigates how tiny glass particles got into the ingredients used for dozens of batches of the drug that were ...
Nov 30, 2012
0
0
Cardiology
Statins plus exercise best at lowering cholesterol, study finds
(HealthDay)—People who exercise along with taking statins to lower their high cholesterol levels can dramatically reduce their risk of dying, a large new study suggests.
Nov 28, 2012
1
0
Medications
Study links improved consumer welfare to increased prescription drug advertising efforts
More people are better off thanks to the impact of an influx of direct-to-consumer advertising spending than they would be without those marketing efforts, according to a study recently published by Jayani Jayawardhana, an ...
Nov 26, 2012
0
0
Medications
Ranbaxy recalls generic Lipitor doses
(AP)—Ranbaxy Pharmaceuticals Inc. has recalled dozens of lots of its generic version of cholesterol drug Lipitor because some may contain tiny glass particles, the latest in a string of manufacturing deficiencies that once ...
Nov 23, 2012
0
0
Arthritis & Rheumatism
Xeljanz approved for rheumatoid arthritis
(HealthDay)—Xeljanz (tofacitinib) has been approved by the U.S. Food and Drug Administration to treat symptoms of rheumatoid arthritis (RA) among people who can't tolerate, or haven't been helped by, the drug methotrexate.
Nov 7, 2012
0
0
Cardiology
New drug may help those who can't take statins
(HealthDay)—An experimental drug may help patients who can't tolerate statins lower their cholesterol, a new Australian study suggests.
Nov 5, 2012
0
0
